Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases. Founded in 2018, Atalanta Therapeutics is backed by investors that include F-Prime Capital and is headquartered in Boston.
The Pulse of New York Tech
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.